The CMS allows doctors to prescribe Medicare patients two different drugs for age-related macular degeneration, one of which costs an average of $54 per dose and the other costs $2,030. Yet 43% of CMS' prescriptions in 2008 and 2009 were for the more-expensive drug—a preference that cost an...
FULL STORY »